Prescription of atypical antipsychotics has increased in recent years. There have also been changes in the guidance on using older drugs, particularly the restriction in the use of thioridazine. We analysed deaths due to poisoning involving antipsychotics in England and Wales, 1993-2002, by age, sex, intent, and agents involved. We also studied antipsychotic prescribing in the community and poisoning deaths in England. Deaths attributed to adverse reactions in the course of normal treatment were not studied because these deaths are not classified as ‘poisonings’. The number of deaths involving antipsychotics increased from around 55 per year 1993-1998 to 74 in 2000, and then fell to 53 in 2002. Around 25% of deaths had a verdict of accidental death and in about 60% of deaths a verdict of suicide or an open verdict was recorded. There were no deaths involving thioridazine in 2002, following its removal from use in 2001. However, the number of deaths associated with atypicals, most notably olanzapine and clozapine, has increased. Age-specific death rates were highest in those aged 30-39 and 40-49 years, and were very low in those aged under 20 and 70 or over. Death rates in males were greater than in females. For many drugs the proportion mentions either alone or with ethanol, was 25-45%, but for clozapine and olanzapine such mentions totalled 65-69%. Deaths per million prescriptions (clozapine excluded) were highest for quetiapine (31.3 per million), chlorpromazine (29.4 per million) and thioridazine (15.5 per million).
Axelsson R, Lagerkvist-Briggs M (1992) Factors predicting suicide in psychotic patients. Eur Arch Psychiatry Clin Neurosci241: 259-266
2.
Balit C R, Isbister G K, Hackett L P, Whyte I M (2003) Quetiapine poisoning: a case series. Ann Emerg Med42: 751-758
3.
Barnes T R E, Kerwin R (2003) Mortality and sudden death in schizophrenia. In Camm J (ed.), Cardiovascular Risk Associated with Schizophrenia and its Treatment. Galliard Healthcare Communications, London, pp. 7-23
4.
Baselt R C (2004) Disposition of toxic drugs and chemicals in man, 7th edn.Biomedical Publications, Foster City, CA
5.
Bateman D N, Good A M, Afshari R, Kelly C A (2003) Effects of licence change on prescribing and poisons enquiries for antipsychotic agents in England and Scotland. Br J Clin Pharmacol55: 596-603
6.
Brock A, Griffiths C (2003) Trends in suicide by method in England and Wales, 1979 to 2001. Hlth Stat Q20: 7-18
7.
Buckley N A, McManus P R (2002) Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. Br Med J325: 1332-1333
8.
Buckley N A, McManus P R (2004) Changes in fatalities due to overdose of anxiolytic and sedative drugs in the UK (1983-1999). Drug Saf27: 135-141
9.
Buckley N, McManus P (1998) Fatal toxicity of drugs used in the treatment of psychotic illnesses. Br J Psychiatr172: 461-464
10.
Caldwell C B, Gottesman I I (1992) Schizophrenia - a high-risk factor for suicide: clues to risk reduction. Suicide Life Threat Behav22: 479-493
11.
Capel M M, Colbridge M G, Henry J A (2000) Overdose profiles of new antipsychotic agents. Int J Neuropsychopharmacol3: 51-54
12.
Christopherson C, Rooney C, Kelly S (1998) Drug-related mortality: methods and trends. Popul Trends93: 1-9
13.
Chue P, Singer P (2003) A review of olanzapine-associated toxicity and fatality in overdose. J Psychiatr Neurosci28: 253-261
14.
Cohen L G, Fatalo A, Thompson B T, Di Centes Bergeron G, Flood J G, Poupolo P R (1999) Olanzapine overdose with serum concentrations. Ann Emerg Med34: 275-278
15.
Davis L E, Becher M W, Tlomak W, Benson B E, Lee R R, Fisher E C (2005) Persistent choreoathetosis in a fatal olanzapine overdose: drug kinetics, neuroimaging, and neuropathology. Am J Psychiatr162: 28-33
16.
Department of Health (1999) Saving lives: Our healthier nation. The Stationery Office, London
17.
Department of Health (2004) Prescription Statistics. http://www.publications.doh.gov.uk/prescriptionstatistics/index.htm
18.
Elian A A (1998) Fatal overdose of olanzapine. Forensic Sci Int91: 231-235
19.
Fernandes P P, Marcil W A (2002) Death associated with quetiapine overdose. Am J Psychiatry159: 2114
20.
Flanagan R J, Rooney C (2002) Recording acute poisoning deaths. Forensic Sci Int128: 3-19
21.
Flanagan R J, Spencer E P, Morgan P E, Barnes T R E, Dunk L (2005) Suspected clozapine poisoning in the UK/Eire, 1992-2003. Forensic Sci Int (in press)
22.
Frey R, Schreinzer D, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S (2002) Fatal poisonings with antidepressive drugs and neuroleptics. Analysis of a correlation with prescriptions in Vienna 1991 to 1997. Nervenarzt73: 629-636
23.
Gerber J E, Cawthon B (2000) Overdose and death with olanzapine: two case reports. Am J Forensic Med Pathol21: 249-251
24.
Henry J, Alexander C A, Sener E K (1995) Relative mortality from overdose of antidepressants. Br Med J310: 221-224
25.
Hopenwasser J, Mozayani A, Danielson T J, Harbin J, Narula H S, Posey D H, Shrode P W, Wilson S K, Li R, Sanchez L A (2004) Postmortem distribution of the novel antipsychotic drug quetiapine. J Anal Toxicol28: 264-267
26.
Langman L J, Kaliciak H A, Carlyle S (2004) Fatal overdoses associated with quetiapine. J Anal Toxicol28: 520-525
27.
Levine B S, Wu S C, Smialek J E (1998) Olanzapine concentrations in forensic investigations. Presented at the annual meeting of the Society of Forensic Toxicologists, Albuquerque, NM, 8 October
28.
Mainland M K, Wagner M A, Gock S B, Wong S H (2001) Quetiapine-related fatalities. J Anal Toxicol25: 381-382
29.
Mason J, Freemantle N, Eccles M (2000) Fatal toxicity associated with antidepressant use in primary care. Br J Gen Pract50: 366-370
30.
Meltzer H Y, Okayli G (1995) Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatr152: 183-190
31.
Merrick T C, Felo J A, Jenkins A J (2001) Tissue distribution of olanzapine in a postmortem case. Am J Forensic Med Pathol22: 270-274
32.
MHRA (2000) Medicines and Healthcare Products Regulatory Agency (medicines) restricts the use of thioridazine. Press release 2000/0734 (http://www.mca.gov.uk/whatsnew/pressreleases/thioridazinepressrelease.htm)
33.
Morgan O, Griffiths C, Baker A, Majeed A (2004) Fatal toxicity of antidepressants in England and Wales, 1993-2002. Hlth Stat Q23: 18-24
34.
Noble B, Drever F, Shah N (1995) Sources and methods. In Drever F (ed.), Occupational Health. HMSO, London, Chapter 2
35.
Nyman A K, Jonsson H (1986) Patterns of self-destructive behaviour in schizophrenia. Acta Psychiatr Scand73: 252-262
36.
Ohberg A, Vuori E, Klaukka T, Lonnqvist J (1998) Antidepressants and suicide mortality. J Affect Disord50: 225-233
37.
O’Malley G F, Seifert S, Heard K, Daly F, Dart R C (1999) Olanzapine overdose mimicking opioid intoxication. Ann Emerg Med34: 279-281
38.
ONS (2004a) Mortality Statistics: Injury and Poisoning. Series DH4. Review of the Registrar General on Deaths Attributed to Injury and Poisoning in England and Wales, 2002. Office for National Statistics, London
39.
ONS (2004b) Deaths related to drug poisoning: England and Wales 1998-2002. Hlth Stat Q21: 59-66
40.
Palenzona S, Meier P J, Kupferschmidt H, Rauber-Luethy C (2004) The clinical picture of olanzapine poisoning with special reference to fluctuating mental status. J Toxicol Clin Toxicol42: 27-32
41.
Pinikahana J, Happell B, Keks N A (2003) Suicide and schizophrenia: a review of literature for the decade (1990-1999) and implications for mental health nursing. Issues Ment Health Nurs24: 27-43
42.
Ray W A, Meador K G (2002) Antipsychotics and sudden death: is thioridazine the only bad actor?Br J Psychiatr180: 483-484
43.
Reilly J G, Ayis S A, Ferrier I N, Jones S J, Thomas S H (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet355: 1048-1052
44.
Reilly J G, Ayis S A, Ferrier I N, Jones S J, Thomas S H (2002) Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatr180: 515-522
45.
Royal College of Psychiatrists (1997) The Association Between Antipsychotic Drugs and Sudden Death. Council Report CR57. Royal College of Psychiatrists, London
46.
Ruschena D, Mullen P E, Burgess P, Cordner S M, Barry-Walsh J, Drummer O H, Palmer S, Browne C, Wallace C (1998) Sudden death in psychiatric patients. Br J Psychiatr172: 331-336
47.
Schreinzer D, Frey R, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S (2001) Different fatal toxicity of neuroleptics identified by autopsy. Eur Neuropsychopharmacol11: 117-124
48.
Shah R, Uren Z, Baker A, Majeed A (2001) Deaths from antidepressants in England and Wales 1993-1997: analysis of a new national database. Psychol Med31: 1203-1210
49.
Shrestha M, Hendrickson R G, Henretig F M (2001) Striking extrapyramidal movements seen in large olanzapine overdoses. Clin Toxicol39: 282
50.
Siris S G (2001) Suicide and schizophrenia. J Psychopharmacol15: 127-135
51.
Stephens B G, Coleman D E, Baselt R C (1998) Olanzapine-related fatality. J Forensic Sci43: 1252-1253
52.
Thompson C (1994) The use of high-dose antipsychotic medication. Br J Psychiatr164: 448-458
53.
Trenton A, Currier G, Zwemer F (2003) Fatalities associated with therapeutic use and overdose of atypical antipsychotics. CNS Drugs17: 307-324
54.
Vivek S (2004) No QT interval prolongation associated with quetiapine overdose. Am J Emerg Med22: 330
55.
Witchel H J, Hancox J C, Nutt D J (2003) Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol23: 58-77
